ArticleBreast cancer research : BCR2026
Dynamic changes in serum HER2-peptide-specific autoantibodies predict response to neoadjuvant therapy in HER2-positive breast cancer.
Tatsuya Yoshida et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.